JAMA Network cover image

JAMA Otolaryngology–Head & Neck Surgery : Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab

JAMA Network

00:00

Advances in Personalized Care and Immunotherapy for HNSCC

This chapter highlights the significance of personalized care and intensified surveillance in treating HPV-negative head and neck squamous cell carcinoma. It also discusses the promise of neoadjuvant immunotherapies and the evolving strategies in evaluating treatment efficacy through immune response.

Play episode from 14:01
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app